Arkolith/Insider Trading/GALT/Form 4

Eldred Kary

DirectorGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Feb 9, 2026
Net Buying
Open-Market Buys
$810
Open-Market Sells
$0
Net Open-Market Flow
$810
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2026Buy(P)300$2.70$81066K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000048) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML